← Open Payments lookup

JOSEPH KARPEL: Open Payments

NPI 1861020190 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,304 in 41 payments from 16 companies in 2025. Trend: 2023 $4,868 · 2024 $2,531 · 2025 $1,304

Food & beverage: $1,304
CompanyPaymentsAmount
ABBVIE INC.13$210
Abbott Laboratories3$191
Tandem Diabetes Care, Inc.3$179
Sequel Med Tech, LLC1$159
BETA BIONICS, INC.5$135
Neurocrine BioSciences, Inc.1$69
Novo Nordisk Inc3$66
Dexcom, Inc.2$51
TOLMAR, INC.2$49
SANOFI-AVENTIS U.S. LLC2$39

Products named: LUPRON DEPOT, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, TWIIST, iLet Bionic Pancreas, CRENESSITY, Dexcom G6 Transmitter, FENSOLVI.

Industry payments across CA — which companies pay providers there.